Portage Biotech Overview
Latest ROE for Portage Biotech: 5501.63% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow5501.63%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, PRTG shows a ROE of 5501.63%. That is above the Energy sector average of 15.17%. Scroll down for historical charts and peer comparison views.
The Energy sector average ROE is about 15.17%. Portage Biotech is at 5501.63%, which is higher that average. That is roughly 36176.2% above the sector mean. Use the comparison chart on this page to see how PRTG stacks up against individual peers as well.
Check the historical chart to see whether PRTG's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Portage Biotech with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Portage Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 5501.63%) with ownership activity and broader fundamentals.
The Energy average ROE is about 15.17%, while PRTG is at 5501.63%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
